Market Overview:
The global chlorothiazide sodium injection market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of hypertension and diabetes, rising geriatric population, and technological advancements in the healthcare sector. Based on type, the global chlorothiazide sodium injection market is segmented into 250mg/vial and 500mg/vial. The 500mg/vial segment is expected to register a higher CAGR during the forecast period as compared to the 250mg/vial segment. This can be attributed to its greater efficacy in controlling blood pressure as compared to 250mg vials. Based on application, the global chlorothiazide sodium injection market is segmented into hospitals, clinics, and recovery centers. The hospitals segment is estimated to account for a larger share of the global chlorothiazide sodium injection market in 2018 owing to an increase in number of hospital admissions for hypertension and diabetes patients across regions worldwide. However, over time clinics are anticipated witness faster growth due rising demand for outpatient care services among people suffering from chronic diseases such as hypertension and diabetes mellitus (DM).
Product Definition:
Chlorothiazide Sodium Injection is a diuretic that helps the body get rid of excess fluid by increasing urine output. It is used to treat high blood pressure, congestive heart failure, and swelling caused by various medical conditions.
250mg/vial:
250mg/vial is the standard dosage of chlorothiazide sodium used for the treatment of hypertension. It's an anti-hypertensive drug that works by relaxing blood vessels, which reduces the pressure in arteries and veins. The reduced pressure causes less stress on heart muscles, lowers your blood sugar levels and helps prevent kidney damage caused by high blood pressure.
500mg/vial:
500mg/vial is a generic medicine used for the treatment of hypertension. It works by relaxing and widening the arteries allowing more blood flow through to the heart which then pumps more easily.
The global Chlorothiazide Sodium Injection market is expected to grow at a significant rate owing to its increased use in treating high blood pressure, angina pectoris, and cardiac failure among others.
Application Insights:
The global chlorothiazide sodium injection market is categorized on the basis of application into hospital, clinics and recovery centers. The hospital segment dominated the market in 2017 owing to increasing prevalence of cardiovascular diseases and kidney stones. Chlorothiazide helps reduce excess fluid retention caused due to edema or ascites by inhibiting the action of thiocyanate-sensitive sodium channels in renal tubules. As a result, it is used for various conditions such as heart failure with edema, liver cirrhosis secondary to chronic alcoholic drinking or pre-existing diabetes mellitus.
Chlorothiazide also has an important role in treating hypertension since it works by relaxing blood vessels thus reducing pressure on kidneys which results in lowering blood pressure levels. It reduces high blood cholesterol levels caused due to its ability to increase excretion of bile acids which acts as a fat emulsifier during digestion process thus preventing formation of gallstones and Heart Valve Disease (HVD).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing cases of hypertension and diabetes, rising healthcare expenditure, and favorable reimbursement policies & regulatory reforms in the U.S. In addition, increasing awareness about new products is also expected to drive growth over the coming years.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving economic conditions and growing patient awareness levels regarding available treatment options for hypertension and diabetes. Moreover, an increase in per capita income has led many people from middle-income groups seeking medical care at hospitals as well as private clinics; this trend will further boost product demand during the projected time frame.
Growth Factors:
- Increasing prevalence of hypertension and diabetes: The increasing prevalence of hypertension and diabetes is a major growth driver for the Chlorothiazide Sodium Injection market. According to the World Health Organization, more than 1.3 billion people worldwide have hypertension, and this number is expected to increase to 1.5 billion by 2025. Similarly, the global prevalence of diabetes is estimated at 422 million in 2014, and it is projected to reach 642 million by 2040. This will lead to an increased demand for Chlorothiazide Sodium Injection products as they are used in the treatment of these diseases.
- Rising geriatric population: The global geriatric population is growing rapidly due to advances in healthcare technology and improvements in living standards around the world. This has led to an increase in the incidence of age-related diseases such as hypertension, heart failure, stroke, and renal impairment which can be treated with Chlorothiazide Sodium Injection products .
Scope Of The Report
Report Attributes
Report Details
Report Title
Chlorothiazide Sodium Injection Market Research Report
By Type
250mg/vial, 500mg/vial
By Application
Hospital, Clinics, Recovery Center
By Companies
Akorn, American Regent, Sagent, Sun Pharma, Fresenius Kabi, Mylan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
184
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Chlorothiazide Sodium Injection Market Report Segments:
The global Chlorothiazide Sodium Injection market is segmented on the basis of:
Types
250mg/vial, 500mg/vial
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Akorn
- American Regent
- Sagent
- Sun Pharma
- Fresenius Kabi
- Mylan
Highlights of The Chlorothiazide Sodium Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 250mg/vial
- 500mg/vial
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chlorothiazide Sodium Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chlorothiazide sodium injection is a medication used to lower blood pressure. It works by relaxing the blood vessels and reducing the amount of fluid that flows through them. This helps to reduce the pressure in your arteries and decrease your risk of heart attack or stroke.
Some of the key players operating in the chlorothiazide sodium injection market are Akorn, American Regent, Sagent, Sun Pharma, Fresenius Kabi, Mylan.
The chlorothiazide sodium injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chlorothiazide Sodium Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chlorothiazide Sodium Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chlorothiazide Sodium Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chlorothiazide Sodium Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chlorothiazide Sodium Injection Market Size & Forecast, 2020-2028
4.5.1 Chlorothiazide Sodium Injection Market Size and Y-o-Y Growth
4.5.2 Chlorothiazide Sodium Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 250mg/vial
5.2.2 500mg/vial
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chlorothiazide Sodium Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chlorothiazide Sodium Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 250mg/vial
9.6.2 500mg/vial
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 250mg/vial
10.6.2 500mg/vial
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 250mg/vial
11.6.2 500mg/vial
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 250mg/vial
12.6.2 500mg/vial
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 250mg/vial
13.6.2 500mg/vial
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chlorothiazide Sodium Injection Market: Competitive Dashboard
14.2 Global Chlorothiazide Sodium Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Akorn
14.3.2 American Regent
14.3.3 Sagent
14.3.4 Sun Pharma
14.3.5 Fresenius Kabi
14.3.6 Mylan
